Agilent Technologies, a top company in life sciences and diagnostics, has a market value of $38 billion and a 10-year compound annual growth rate (CAGR) of 13.6%. Its financial highlights include steady revenue growth, a gross profit margin consistently over 50%, and a strong return on invested capital, even with some ups and downs. After its latest earnings report, the stock price dropped significantly, presenting a great buying opportunity at its current price.
While Agilent's revenue and earnings per share (EPS) provide insight into its performance for the quarter ending in January 2025, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Agilent Technologies (A) reported quarterly earnings of $1.31 per share, which is higher than the Zacks Consensus Estimate of $1.27 per share. This is an increase compared to earnings of $1.29 per share from the same period last year.
On Wednesday, Agilent, a company that makes medical equipment, reduced its yearly revenue predictions. They anticipate weak demand for their medical tools and equipment from smaller biotech firms.
A's financial results for the first quarter are probably affected by rising costs, more capital expenditures, and the change in timing of the Lunar New Year.
In addition to Wall Street's predictions for Agilent's (A) earnings and revenue, take a look at forecasts for some important metrics to better understand how the company performed in the quarter that ended in January 2025.
US stocks fell on Friday afternoon, primarily driven by losses in the automotive sector and Chinese firms. This decline came after the White House announced that President Donald Trump plans to implement 25% tariffs on Mexico and Canada, along with a 10% tax on China starting Saturday.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will announce its financial results for the first quarter of fiscal year 2025 after the market closes on Wednesday, February 26. The company will also hold a conference call to go over the results at 1:30 p.m. PST. To listen to the call, you can find the link in the Events section of Agilent's investor relations website, where a recording will be available for 90 days.
A is experiencing difficulties due to decreasing demand in the market and regulatory issues in China, which is causing worries about its growth.
Agilent Technologies, Inc. (NYSE:A) will be participating in the 43rd Annual Healthcare Conference hosted by J.P. Morgan on January 14, 2025, at 12:45 PM ET. The company will be represented by Padraig McDonnell, the President and CEO, and Robert McMahon, the Senior VP and CFO. Rachel Vatnsdal from JPMorgan will be among the conference call participants.